{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:24:56Z","timestamp":1762507496218,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bbmt.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T23:38:11Z","timestamp":1535067491000},"page":"2493-2500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Donor KIR Genotype Impacts on Clinical Outcome after T Cell\u2013Depleted HLA Matched Related Allogeneic Transplantation for High-Risk Pediatric Leukemia Patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Adela","family":"Escudero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mart\u00ednez-Romera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Valent\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gonz\u00e1lez-Vicent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Madero-Jarabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.08.009_bib0001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0002","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0003","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2017.00496","article-title":"Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia","volume":"8","author":"Dickinson","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0004","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/bmt.2016.62","article-title":"Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantation","volume":"51","author":"Solh","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0006","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bmt.2017.22","article-title":"Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future","volume":"52","author":"Saad","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0007","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2141.2007.06911.x","article-title":"Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients","volume":"140","author":"Perez","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0008","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ncponc0848","article-title":"Experimental and clinical approaches for optimization of the graft-versus-leukemia effect","volume":"4","author":"Sprangers","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0009","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2011.11.024","article-title":"T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome","volume":"18","author":"Weisdorf","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0010","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.bbmt.2006.08.034","article-title":"T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome","volume":"12","author":"Montero","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0011","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbmt.2006.04.008","article-title":"KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy","volume":"12","author":"Hsu K","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0013","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1182\/blood-2007-01-065383","article-title":"Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT","volume":"109","author":"Miller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2249.2009.03983.x","article-title":"Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias","volume":"157","author":"Moretta","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0015","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1158\/1078-0432.CCR-13-1766","article-title":"Infusions of allogeneic natural killer cells as cancer therapy","volume":"20","author":"Leung","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0016","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes","volume":"7","author":"Uhrberg","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imr.12316","article-title":"Human KIR repertoires: shaped by genetic diversity and evolution","volume":"267","author":"Manser","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0018","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0019","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbmt.2017.11.042","volume":"24","author":"Wanquet","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.seminhematol.2016.07.001","article-title":"Haploidentical transplants using ex vivo T-cell depletion","volume":"53","author":"Martelli","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0021","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood-2005-04-1644","article-title":"KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation","volume":"106","author":"Cooley","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0022","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.bmt.1703136","article-title":"Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)\u2013results of a prospective randomised monocentre study","volume":"28","author":"Bonig","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pbc.21955","article-title":"KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors","volume":"53","author":"Perez-Martinez","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0025","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.tp.0000235859.24513.43","article-title":"Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation","volume":"82","author":"Kroger","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0026","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.transproceed.2016.07.037","article-title":"Report from the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External quality control for natural killer alloreactive donor selection in haploidentical stem cell transplantation","volume":"48","author":"Planelles","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0027","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determinants of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0028","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","article-title":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia","volume":"113","author":"Cooley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0029","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1158\/1078-0432.CCR-14-0479","article-title":"NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease","volume":"20","author":"Sullivan","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0030","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/leu.2009.21","article-title":"Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies","volume":"23","author":"Triplett","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0031","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the 'missing self': MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0032","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0033","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2004-08-3156","article-title":"A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules","volume":"105","author":"Fernandez","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0034","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.smim.2006.03.003","article-title":"Missing self recognition and self tolerance of natural killer (NK) cells","volume":"18","author":"Raulet","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0036","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.4049\/jimmunol.167.6.3129","article-title":"Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15","volume":"167","author":"Dunne","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0037","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0038","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00018-012-0968-7","article-title":"Homeostatic maintenance of T cells and natural killer cells","volume":"69","author":"Boyman","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0039","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/leusup.2014.9","article-title":"Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?","volume":"3","author":"Kolb","year":"2014","journal-title":"Leukemia Suppl"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0040","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0041","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/asheducation-2014.1.565","article-title":"Cytotoxic T lymphocytes for leukemia and lymphoma","volume":"2014","author":"Bollard","year":"2014","journal-title":"Hematology"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0042","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2009-07-229740","article-title":"NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation","volume":"115","author":"Bjorklund","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0043","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.0001-2815.2004.00182.x","article-title":"The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD","volume":"63","author":"Bishara","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0044","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.transproceed.2005.11.091","article-title":"Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation","volume":"38","author":"Giebel","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1600-0609.2009.01280.x","article-title":"Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Giebel","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0046","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2010.03.004","article-title":"Donor KIR genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies","volume":"16","author":"Stringaris","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0047","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2014.00405","article-title":"Donor haplotype B of NK KIR receptor reduces the relapse risk in HLA-identical sibling hematopoietic stem cell transplantation of AML patients","volume":"5","author":"Impola","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0048","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.humimm.2017.10.004","article-title":"The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling","volume":"78","author":"Elfishawi","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0049","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbmt.2009.10.021","article-title":"The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings","volume":"16","author":"Clausen","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0051","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/bmt.2009.303","article-title":"Effect of missing killer-immunoglobulin-like receptor ligand in recipients undergoing HLA full matched, non-T-depleted sibling donor transplantation: a single institution experience of 151 Asian patients","volume":"45","author":"Linn","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0052","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/tan.12829","article-title":"The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients","volume":"87","author":"Khanuntong","year":"2016","journal-title":"HLA"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0053","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2141.2003.04604.x","article-title":"T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation","volume":"123","author":"Lowe","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2018.08.009_bib0054","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbmt.2006.09.009","article-title":"Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients","volume":"13","author":"Sun","year":"2007","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118304749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118304749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:03Z","timestamp":1761059103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118304749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1083879118304749"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.08.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor KIR Genotype Impacts on Clinical Outcome after T Cell\u2013Depleted HLA Matched Related Allogeneic Transplantation for High-Risk Pediatric Leukemia Patients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}